Fortress Biotech, Inc. (FBIO)
2.35
-0.16
(-6.37%)
USD |
NASDAQ |
Apr 07, 16:00
2.335
-0.02
(-0.64%)
After-Hours: 20:00
Fortress Biotech Profit Margin (Quarterly) : -33.57% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Journey Medical Corp. | -7.76% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Oramed Pharmaceuticals, Inc. | -- |
| Avenue Therapeutics, Inc. | -- |
| Lyell Immunopharma, Inc. | -2.35M% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -84.14% |
| Return on Assets | -19.38% |
| Return on Invested Capital | -29.89% |
| Gross Profit Margin (Quarterly) | 58.97% |
| Operating Margin (Quarterly) | -29.78% |
| Return on Net Operating Assets | -43.21% |